F&FFinancial Insights

Financial Metrics

LFST LifeStance Health Group, Inc.
Range: 2016-01-01 to 2026-04-29
Chart Range:
% Change:

Financial Statements

Grouped by statement

Income Statement

Metrics: 6

Revenue

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-05-14 111661000.0 USD 10-Q 2021-11-10
Quarterly 2020-06-30 45453000.0 -59.3% USD 10-Q 2021-08-12
Quarterly 2020-09-30 101982000.0 +124.4% USD 10-Q 2021-11-10
Quarterly 2021-03-31 143132000.0 +40.4% USD 10-Q 2022-05-11
Quarterly 2021-06-30 160549000.0 +12.2% USD 10-Q 2022-08-10
Quarterly 2021-09-30 173835000.0 +8.3% USD 10-Q 2022-11-09
Quarterly 2022-03-31 203095000.0 +16.8% USD 10-Q 2023-05-10
Quarterly 2022-06-30 209527000.0 +3.2% USD 10-Q 2023-08-09
Quarterly 2022-09-30 217560000.0 +3.8% USD 10-Q 2023-11-08
Quarterly 2023-03-31 252589000.0 +16.1% USD 10-Q 2024-05-09
Quarterly 2023-06-30 259578000.0 +2.8% USD 10-Q 2024-08-08
Quarterly 2023-09-30 262895000.0 +1.3% USD 10-Q 2024-11-07
Quarterly 2024-03-31 300437000.0 +14.3% USD 10-Q 2025-05-07
Quarterly 2024-06-30 312331000.0 +4.0% USD 10-Q 2025-08-07
Quarterly 2024-09-30 312722000.0 +0.1% USD 10-Q 2025-11-06
Quarterly 2025-03-31 332970000.0 +6.5% USD 10-Q 2025-05-07
Quarterly 2025-06-30 345311000.0 +3.7% USD 10-Q 2025-08-07
Quarterly 2025-09-30 363809000.0 +5.4% USD 10-Q 2025-11-06
Annual 2019-12-31 212518000.0 USD 10-K 2022-03-17
Annual 2020-12-31 265556000.0 +25.0% USD 10-K 2023-03-09
Annual 2021-12-31 667511000.0 +151.4% USD 10-K 2024-02-28
Annual 2022-12-31 859542000.0 +28.8% USD 10-K 2025-02-27
Annual 2023-12-31 1055665000.0 +22.8% USD 10-K 2026-02-25
Annual 2024-12-31 1250970000.0 +18.5% USD 10-K 2026-02-25
Annual 2025-12-31 1424285000.0 +13.9% USD 10-K 2026-02-25

Gross Profit

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

Operating Income

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-05-14 8695000.0 USD 10-Q 2021-11-10
Quarterly 2020-06-30 104000.0 -98.8% USD 10-Q 2021-08-12
Quarterly 2020-09-30 2691000.0 +2487.5% USD 10-Q 2021-11-10
Quarterly 2021-03-31 -881000.0 -132.7% USD 10-Q 2022-05-11
Quarterly 2021-06-30 -47045000.0 -5240.0% USD 10-Q 2022-08-10
Quarterly 2021-09-30 -124668000.0 -165.0% USD 10-Q 2022-11-09
Quarterly 2022-03-31 -64851000.0 +48.0% USD 10-Q 2023-05-10
Quarterly 2022-06-30 -60472000.0 +6.8% USD 10-Q 2023-08-09
Quarterly 2022-09-30 -38839000.0 +35.8% USD 10-Q 2023-11-08
Quarterly 2023-03-31 -34093000.0 +12.2% USD 10-Q 2024-05-09
Quarterly 2023-06-30 -48413000.0 -42.0% USD 10-Q 2024-08-08
Quarterly 2023-09-30 -74357000.0 -53.6% USD 10-Q 2024-11-07
Quarterly 2024-03-31 -16772000.0 +77.4% USD 10-Q 2025-05-07
Quarterly 2024-06-30 -15947000.0 +4.9% USD 10-Q 2025-08-07
Quarterly 2024-09-30 47000.0 +100.3% USD 10-Q 2025-11-06
Quarterly 2025-03-31 1604000.0 +3312.8% USD 10-Q 2025-05-07
Quarterly 2025-06-30 -2950000.0 -283.9% USD 10-Q 2025-08-07
Quarterly 2025-09-30 7410000.0 +351.2% USD 10-Q 2025-11-06
Annual 2019-12-31 15241000.0 USD 10-K 2022-03-17
Annual 2020-12-31 6741000.0 -55.8% USD 10-K 2023-03-09
Annual 2021-12-31 -286353000.0 -4347.9% USD 10-K 2024-02-28
Annual 2022-12-31 -210174000.0 +26.6% USD 10-K 2025-02-27
Annual 2023-12-31 -189134000.0 +10.0% USD 10-K 2026-02-25
Annual 2024-12-31 -31613000.0 +83.3% USD 10-K 2026-02-25
Annual 2025-12-31 24148000.0 +176.4% USD 10-K 2026-02-25

Net Income

Q: 18 | A: 7

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed
Quarterly 2020-05-14 -24945000.0 USD 10-Q 2021-11-10
Quarterly 2020-06-30 -4342000.0 +82.6% USD 10-Q 2021-08-12
Quarterly 2020-09-30 -7636000.0 -75.9% USD 10-Q 2021-11-10
Quarterly 2021-03-31 -8682000.0 -13.7% USD 10-Q 2022-05-11
Quarterly 2021-06-30 -78715000.0 -806.6% USD 10-Q 2022-08-10
Quarterly 2021-09-30 -199167000.0 -153.0% USD 10-Q 2022-11-09
Quarterly 2022-03-31 -62328000.0 +68.7% USD 10-Q 2023-05-10
Quarterly 2022-06-30 -131055000.0 -110.3% USD 10-Q 2023-08-09
Quarterly 2022-09-30 -168908000.0 -28.9% USD 10-Q 2023-11-08
Quarterly 2023-03-31 -34242000.0 +79.7% USD 10-Q 2024-05-09
Quarterly 2023-06-30 -79720000.0 -132.8% USD 10-Q 2024-08-08
Quarterly 2023-09-30 -141303000.0 -77.2% USD 10-Q 2024-11-07
Quarterly 2024-03-31 -21097000.0 +85.1% USD 10-Q 2025-05-07
Quarterly 2024-06-30 -44374000.0 -110.3% USD 10-Q 2025-08-07
Quarterly 2024-09-30 -50331000.0 -13.4% USD 10-Q 2025-11-06
Quarterly 2025-03-31 709000.0 +101.4% USD 10-Q 2025-05-07
Quarterly 2025-06-30 -3082000.0 -534.7% USD 10-Q 2025-08-07
Quarterly 2025-09-30 -2005000.0 +34.9% USD 10-Q 2025-11-06
Annual 2019-12-31 5669000.0 USD 10-K 2022-03-17
Annual 2020-12-31 -13125000.0 -331.5% USD 10-K 2023-03-09
Annual 2021-12-31 -307197000.0 -2240.5% USD 10-K 2024-02-28
Annual 2022-12-31 -215564000.0 +29.8% USD 10-K 2025-02-27
Annual 2023-12-31 -186262000.0 +13.6% USD 10-K 2026-02-25
Annual 2024-12-31 -57443000.0 +69.2% USD 10-K 2026-02-25
Annual 2025-12-31 9663000.0 +116.8% USD 10-K 2026-02-25

EPS Basic

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

EPS Diluted

Q: 0 | A: 0

Quarterly

Annual

Show Data Rows
Frequency Period End Value % Chg Unit Form Filed

8-K Material Event Details

38 filings · 97 item records

This 8-K section tracks corporate event disclosures, not insider buy/sell sentiment. Insider trading direction is shown in the insider section below.

Event Type Distribution

Count per 8-K item

Insider Transaction History

127 transaction records

Net Insider Flow

Monthly open-market buy value minus open-market sell value

Monthly Insider Activity Mix

Share volume split between open-market trades, grants, and exercises

Transaction Value Timeline

Each circle = one priced transaction; size ∝ value

All Transactions

Date Insider Title Type Security Shares Price Total Value Post-Tx Shares
2026-04-01 Pardo Ryan See Remarks Other disposed transaction
F
Common Stock 9,376 $6.37 $59,725 1,093,366
2026-03-24 McGroarty Ryan See Remarks Other disposed transaction
F
Common Stock 24,255 $6.45 $156,445 772,235
2026-03-17 McGroarty Ryan See Remarks Other disposed transaction
F
Common Stock 47,594 $6.89 $327,923 796,490
2026-03-09 Burdick Kenneth A Other disposed transaction
F
Common Stock 278,192 $6.91 $1,922,307 3,425,315
2026-03-09 Burdick Kenneth A Equity grant / award
A
Common Stock 706,960 $0.00 $0 3,703,507
2026-03-09 Burdick Kenneth A Other disposed transaction
F
Common Stock 13,201 $6.91 $91,219 2,996,547
2026-03-09 Burdick Kenneth A Equity grant / award
A
Common Stock 33,544 $0.00 $0 3,009,748
2026-03-09 Burdick Kenneth A Other disposed transaction
F
Common Stock 35,816 $6.91 $247,489 2,976,204
2026-03-06 Burdick Kenneth A Other disposed transaction
F
Common Stock 424,551 $7.11 $3,018,558 3,012,020
2026-03-05 Eken Stephanie Carin Chief Medical Officer Equity grant / award
A
Common Stock 115,107 $0.00 $0 115,107
2026-03-02 TPG GP A, LLC 10% Open-market sell
S
Common Stock 20,685,061 $7.01 $145,002,278 140,026,557
2025-12-22 Bessler Robert Open-market sell
S
Common Stock 851 $7.04 $5,991 1,434,932
2025-12-22 Bessler Robert Open-market sell
S
Common Stock 850 $7.04 $5,984 1,318,133
2025-12-19 Bessler Robert Open-market sell
S
Common Stock 59,971 $7.04 $422,196 1,435,783
2025-12-18 Bessler Robert Open-market sell
S
Common Stock 3,221 $7.00 $22,547 1,495,754
2025-12-17 Varanakis Ann Chief People Officer Open-market sell
S
Common Stock 50,000 $6.90 $345,000 315,610
2025-12-15 Bessler Robert Open-market sell
S
Common Stock 6,185 $7.00 $43,295 1,492,790
2025-12-15 Bessler Robert Open-market sell
S
Common Stock 6,186 $7.00 $43,302 1,375,989
2025-12-12 Bessler Robert Open-market sell
S
Common Stock 39,815 $7.01 $279,103 1,498,975
2025-11-21 Miller Lisa K See Remarks Open-market sell
S
Common Stock 57,240 $6.43 $368,053 261,292
2025-11-10 Miller Lisa K See Remarks Other disposed transaction
F
Common Stock 10,623 $6.43 $68,306 318,532
2025-08-26 Varanakis Ann Chief People Officer Other disposed transaction
F
Common Stock 5,233 $5.39 $28,206 369,335
2025-08-20 Personette Sarah Equity grant / award
A
Common Stock 74,766 $0.00 $0 74,766
2025-08-18 Silversmith Partners I GP, LLC Open-market sell
S
Common Stock 3,592,357 $5.07 $18,213,250 14,324,197
2025-08-11 Burdick Kenneth A Open-market buy
P
Common Stock 18,660 $4.54 $84,716 3,436,571
2025-08-11 Burdick Kenneth A Open-market buy
P
Common Stock 1,340 $4.35 $5,829 3,417,991
2025-08-08 Burdick Kenneth A Open-market buy
P
Common Stock 46,511 $4.30 $199,997 46,511
2025-08-08 Burdick Kenneth A Open-market buy
P
Common Stock 1,800 $4.31 $7,758 3,416,571
2025-08-08 Burdick Kenneth A Open-market buy
P
Common Stock 45,870 $4.36 $199,993 3,414,771
2025-06-16 Ramtekkar Ujjwal Chief Medical Officer Open-market sell
S
Common Stock 9,519 $5.17 $49,213 103,916
2025-06-11 Paunovich Vukasin Chief Technology Officer Equity grant / award
A
Common Stock 178,571 $0.00 $0 178,571
2025-06-05 Ramtekkar Ujjwal Chief Medical Officer Open-market sell
S
Common Stock 16,000 $5.94 $95,040 113,435
2025-04-09 Bessler Robert Open-market sell
S
Common Stock 2,450 $7.01 $17,174 1,538,790
2025-04-08 Bessler Robert Open-market sell
S
Common Stock 7 $7.00 $49 1,541,240
2025-04-01 Pardo Ryan See Remarks Other disposed transaction
F
Common Stock 9,377 $6.63 $62,170 928,015
2025-03-24 McGroarty Ryan See Remarks Equity grant / award
A
Common Stock 184,911 $0.00 $0 547,755
2025-03-17 McGroarty Ryan See Remarks Equity grant / award
A · derivative
Stock Option (right to buy) 725,689 $0.00 $0 725,689
2025-03-17 McGroarty Ryan See Remarks Equity grant / award
A
Common Stock 362,844 $0.00 $0 362,844
2025-03-10 Pantaleoni Pablo Chief Digital Officer Open-market sell
S
Common Stock 15,605 $7.64 $119,222 522,580
2025-03-10 Pardo Ryan See Remarks Other disposed transaction
F
Common Stock 12,280 $7.11 $87,311 915,735
2025-03-07 Varanakis Ann Chief People Officer Other disposed transaction
F
Common Stock 8,606 $7.59 $65,320 376,430
2025-03-07 Varanakis Ann Chief People Officer Equity grant / award
A
Common Stock 32,052 $0.00 $0 385,036
2025-03-07 Varanakis Ann Chief People Officer Other disposed transaction
F
Common Stock 7,450 $7.59 $56,546 352,984
2025-03-07 Varanakis Ann Chief People Officer Equity grant / award
A
Common Stock 27,740 $0.00 $0 360,434
2025-03-07 Pantaleoni Pablo Chief Digital Officer Open-market sell
S
Common Stock 19,900 $7.29 $145,071 538,185
2025-03-06 Miller Lisa K See Remarks Other disposed transaction
F
Common Stock 6,431 $7.88 $50,676 358,655
2025-03-06 Miller Lisa K See Remarks Equity grant / award
A
Common Stock 76,142 $0.00 $0 365,086
2025-03-06 Varanakis Ann Chief People Officer Other disposed transaction
F
Common Stock 6,455 $7.88 $50,865 332,694
2025-03-06 Varanakis Ann Chief People Officer Equity grant / award
A
Common Stock 76,142 $0.00 $0 339,149
2024-11-27 Bessler Robert Open-market sell
S
Common Stock 37,500 $7.54 $282,750 1,541,247
2024-11-13 Miller Lisa K See Remarks Open-market sell
S
Common Stock 10,540 $7.45 $78,523 288,994
2024-08-23 Varanakis Ann Chief People Officer Open-market sell
S
Common Stock 5,269 $6.28 $33,089 263,007
2024-08-14 DeLuca Teresa Equity grant / award
A
Common Stock 35,211 $0.00 $0 71,574
2024-07-21 DeLuca Teresa Equity grant / award
A
Common Stock 36,363 $0.00 $0 36,363
2024-06-14 Qureshi Danish J. See Remarks Open-market sell
S
Common Stock 150,000 $5.21 $781,515 439,002
2024-06-12 Pardo Ryan See Remarks Open-market sell
S
Common Stock 61,508 $5.40 $332,143 746,439
2024-06-11 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 85,093 $5.53 $470,564 4,650,571
2024-06-10 Qureshi Danish J. See Remarks Open-market sell
S
Common Stock 83,109 $5.25 $436,322 4,827,941
2024-05-24 Summit Partners Growth Equity Fund IX-A, L.P. Open-market sell
S
Common Stock 3,802,345 $5.89 $22,395,812 41,932,358
2024-05-13 Cipollone Paula See Remarks Open-market sell
S
Common Stock 48,278 $7.22 $348,567 239,915
2024-05-10 Cipollone Paula See Remarks Open-market sell
S
Common Stock 2,000 $7.00 $14,000 288,193
2024-04-01 Qureshi Danish J. See Remarks Open-market sell
S
Common Stock 12,965 $5.93 $76,882 4,911,050
2024-03-15 Burdick Kenneth A Chief Executive Officer Open-market sell
S
Common Stock 214,605 $6.28 $1,347,719 2,934,372
2024-03-14 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 44,540 $6.33 $281,938 4,745,352
2024-03-13 Qureshi Danish J. See Remarks Open-market sell
S
Common Stock 153,943 $6.32 $972,920 4,924,015
2024-03-12 Pantaleoni Pablo Chief Digital Officer Open-market sell
S
Common Stock 43,304 $6.76 $292,735 1,310,043
2024-03-08 Ramtekkar Ujjwal Chief Medical Officer Equity grant / award
A
Common Stock 62,413 $0.00 $0 62,413
2024-03-01 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 115,136 $8.02 $923,391 4,575,480
2024-01-03 Cipollone Paula See Remarks Open-market sell
S
Common Stock 3,369 $7.45 $25,099 290,193
2023-12-01 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 113,334 $6.54 $741,204 4,690,616
2023-11-07 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 32,056 $6.12 $196,183 4,803,950
2023-11-06 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 300 $6.12 $1,836 4,836,006
2023-11-03 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 80,977 $6.13 $496,389 4,836,306
2023-10-02 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 113,333 $6.61 $749,131 4,917,283
2023-09-01 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 38,058 $8.25 $313,978 5,818,204
2023-08-31 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 11,966 $8.25 $98,720 5,856,262
2023-08-24 Varanakis Ann Chief People Officer Open-market sell
S
Common Stock 5,661 $7.60 $43,024 168,441
2023-07-06 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 135,400 $8.67 $1,173,918 5,030,616
2023-07-05 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 150,000 $8.72 $1,308,000 5,166,016
2023-07-03 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 54,600 $9.00 $491,400 5,316,016
2023-07-01 Shuey Eric Dir Equity grant / award
A
Common Stock 21,905 $0.00 $0 21,905
2023-06-28 Patel-Dunn Anisha Chief Medical Officer Open-market sell
S
Common Stock 2,602 $9.24 $24,042 277,055
2023-06-26 Pardo Ryan See Remarks Open-market sell
S
Common Stock 50,136 $8.91 $446,712 636,461
2023-06-23 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 65,832 $9.02 $593,805 5,370,616
2023-06-22 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 57,754 $9.05 $522,674 5,868,228
2023-06-21 Qureshi Danish J. See Remarks Open-market sell
S
Common Stock 587 $9.07 $5,324 4,583,404
2023-06-21 Qureshi Danish J. See Remarks Open-market sell
S
Common Stock 71,811 $9.03 $648,453 4,583,991
2023-06-14 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 45,984 $8.95 $411,557 5,925,982
2023-06-13 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 47,142 $8.71 $410,607 5,971,966
2023-06-12 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 2,858 $8.51 $24,322 6,019,108
2023-04-04 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 69,734 $7.61 $530,676 5,436,448
2023-04-03 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 97,266 $7.43 $722,686 5,512,581
2023-03-16 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 43,705 $6.14 $268,349 5,609,847
2023-03-15 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 200 $6.11 $1,222 5,653,552
2023-03-14 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 800 $6.11 $4,888 5,653,752
2023-03-08 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 122,295 $6.12 $748,445 5,654,552
2023-03-06 Bourdon David Chief Financial Officer Equity grant / award
A
Common Stock 160,256 $0.00 $0 264,016
2022-11-10 Bourdon David Chief Financial Officer Equity grant / award
A · derivative
Stock Option (right to buy) 1,250,000 $0.00 $0 1,250,000
2022-11-10 Bourdon David Chief Financial Officer Other disposed transaction
F
Common Stock 77,072 $5.53 $426,208 103,760
2022-11-10 Bourdon David Chief Financial Officer Equity grant / award
A
Common Stock 180,832 $0.00 $0 180,832
2022-11-07 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 15,106 $7.20 $108,763 5,967,991
2022-10-31 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 15,106 $7.49 $113,144 5,983,097
2022-10-24 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 15,106 $7.06 $106,648 5,998,203
2022-10-17 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 15,106 $8.01 $120,999 6,013,309
2022-10-10 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 15,106 $7.45 $112,540 6,028,415
2022-10-03 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 15,106 $7.02 $106,044 6,043,521
2022-09-30 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 82,520 $7.03 $580,116 5,584,540
2022-09-08 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 51,672 $9.01 $465,565 6,058,627
2022-09-07 Burdick Kenneth A Chief Executive Officer Equity grant / award
A · derivative
Stock Option (right to buy) 9,404,539 $0.00 $0 9,404,539
2022-09-06 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 34,449 $7.00 $241,143 6,110,299
2022-08-23 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 17,226 $7.02 $120,927 6,144,748
2022-08-15 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 17,226 $7.85 $135,224 6,161,974
2022-08-08 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 17,226 $7.30 $125,750 6,179,200
2022-08-03 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 68,904 $7.00 $482,328 6,196,426
2022-06-13 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 67,479 $5.32 $358,988 6,275,330
2022-06-13 Patel-Dunn Anisha Chief Medical Officer Open-market sell
S
Common Stock 3,463 $5.34 $18,492 94,669
2022-06-09 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 10,000 $7.32 $73,200 6,265,330
2022-06-09 Gouk Warren Chief Administrative Officer Open-market sell
S
Common Stock 10,000 $7.32 $73,200 6,265,330
2022-04-25 Booth Gwen H. Chief Operating Officer Equity grant / award
A
Common Stock 76,457 $0.00 $0 7,172,435
2022-04-20 Mullins Kevin Michael Chief Development Officer Open-market sell
S
Common Stock 46,283 $10.68 $494,302 5,669,472
2022-03-15 Bruff Jesse Michael Chief Financial Officer Open-market sell
S
Common Stock 86 $8.86 $762 1,816,704
2022-03-14 Bruff Jesse Michael Chief Financial Officer Open-market sell
S
Common Stock 18,401 $7.92 $145,736 1,816,790
2021-12-31 Bruff Jesse Michael Chief Financial Officer Other disposed transaction
F
Common Stock 40,346 $9.23 $372,394 1,835,191
2021-08-22 Verma Seema Dir Equity grant / award
A
Common Stock 79,543 $0.00 $0 79,543
2021-06-25 Summit Partners Growth Equity Fund IX-A, L.P. 10% Open-market sell
S
Common Stock 1,140,704 $17.01 $19,403,375 45,734,703
2021-06-14 BLACK DARREN M. Dir Open-market sell
S
Common Stock 1,368,844 $17.01 $23,284,036 46,875,407
2021-06-09 BLACK DARREN M. Dir Equity grant / award
A
Common Stock 48,244,251 48,244,251

Regulatory Activity

Last 12 months to 2025-04-29
Insider Filings (Forms 3/4/5) — 12 months
27
Material Event Filings (8-K) — 12 months
8

8-K Material Event Filing Activity

Monthly count

Insider Trading Activity (Forms 3/4/5)

Monthly count
For informational purposes only — not guaranteed to be accurate or complete.